Price$2.71+0.31 (+12.71%)
2026-03-042026-06-05
News · 26 weeks35+63%
2025-12-142026-06-07
Mix3090d
- Insider17(57%)
- SEC Filings8(27%)
- Other3(10%)
- Earnings2(7%)
Latest news
25 items- SECSEC Form SD filed by Accendra Health Inc.SD - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)
- SECAccendra Health Inc. filed SEC Form 8-K: Regulation FD Disclosure8-K - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)
- PRAccendra Health Announces Offers and Consent SolicitationsAccendra Health, Inc. (NYSE:ACH) (the "Company") today announced that it has commenced an offer to exchange (the "Exchange Offers") any and all of the Company's outstanding 4.500% Senior Notes due 2029 (the "2029 Notes") and 6.625% Senior Notes due 2030 (the "2030 Notes" and, together with the 2029 Notes, the "Existing Notes"). Eligible Holders of 2029 Notes that participate in the New Money Notes Issuance (as defined below) will be able to exchange such 2029 Notes for newly issued 9.000% Senior Secured First Lien Notes due 2032 (the "First Lien Notes") and newly issued 9.750% Senior Secured Second Lien Notes due 2033 (the "Second Lien Notes" and, together with the First Lien Notes, the "Ne
- INSIDEREVP,General Counsel & CorpSecy Galloway Heath H covered exercise/tax liability with 1,822 shares, decreasing direct ownership by 1% to 166,306 units (SEC Form 4) to satisfy withholding obligation4 - ACCENDRA HEALTH INC/VA/ (0000075252) (Issuer)
- INSIDEREVP & CFO Leon Jonathan A covered exercise/tax liability with 1,770 shares, decreasing direct ownership by 0.61% to 290,533 units (SEC Form 4) to cover withholding tax4 - ACCENDRA HEALTH INC/VA/ (0000075252) (Issuer)
- INSIDERPresident & CEO Pesicka Edward A covered exercise/tax liability with 17,692 shares, decreasing direct ownership by 2% to 1,072,785 units (SEC Form 4) to satisfy withholding obligation4 - ACCENDRA HEALTH INC/VA/ (0000075252) (Issuer)
- INSIDEREVP,General Counsel & CorpSecy Galloway Heath H covered exercise/tax liability with 966 shares, decreasing direct ownership by 0.57% to 168,128 units (SEC Form 4) (tax liability)4 - ACCENDRA HEALTH INC/VA/ (0000075252) (Issuer)
- INSIDEREVP, Chief Operating Officer Bernocchi Perry A covered exercise/tax liability with 7,908 shares, decreasing direct ownership by 2% to 313,913 units (SEC Form 4) to satisfy withholding tax4 - ACCENDRA HEALTH INC/VA/ (0000075252) (Issuer)
- INSIDERDirector Kline Teresa L. was granted 31,191 shares, increasing direct ownership by 58% to 85,316 units (SEC Form 4)4 - ACCENDRA HEALTH INC/VA/ (0000075252) (Issuer)
- INSIDERDirector Klemash Stephen W was granted 31,191 shares, increasing direct ownership by 53% to 90,242 units (SEC Form 4)4 - ACCENDRA HEALTH INC/VA/ (0000075252) (Issuer)
- INSIDERDirector Gardner-Smith Kenneth was granted 31,191 shares, increasing direct ownership by 57% to 86,113 units (SEC Form 4)4 - ACCENDRA HEALTH INC/VA/ (0000075252) (Issuer)
- INSIDERDirector Beck Mark A was granted 31,191 shares, increasing direct ownership by 78% to 71,259 units (SEC Form 4)4 - ACCENDRA HEALTH INC/VA/ (0000075252) (Issuer)
- INSIDERSEC Form 4 filed by Director Bingham Gwendolyn M4 - ACCENDRA HEALTH INC/VA/ (0000075252) (Issuer)
- SECSEC Form S-8 filed by Accendra Health Inc.S-8 - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)
- SECAccendra Health Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders8-K - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Accendra Health Inc.SCHEDULE 13G/A - ACCENDRA HEALTH INC/VA/ (0000075252) (Subject)
- SECSEC Form 10-Q filed by Accendra Health Inc.10-Q - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)
- SECAccendra Health Inc. filed SEC Form 8-K: Regulation FD Disclosure8-K - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)
- SECAccendra Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)
- PRAccendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization TransactionCommitments in Place from Existing Creditors to Strengthen Balance Sheet, Extend Maturities, and Reduce Leverage Accendra Health, Inc. (NYSE:ACH) today reported financial results for the first quarter ended March 31, 2026, and announced a more than $1.5 billion comprehensive balance sheet optimization transaction with commitments from existing creditors that will strengthen the balance sheet, significantly extend maturities and reduce total leverage. Unless otherwise noted, the results herein reflect the Company's continuing operations, which represent what was previously the Patient Direct segment and certain functional operations. "Our first quarter results were aligned with our expec
- PRAccendra Health Announces First Quarter 2026 Earnings Release Date and Conference CallAccendra Health, Inc. (NYSE:ACH) (the "Company") plans to release financial results for the first quarter of 2026 on Monday, May 11, 2026, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:30 a.m. EDT on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the Investor Relations page of the Accendra Health website available at investors.accendra.com/events-and-presentations/. A replay of
- SECSEC Form DEFA14A filed by Accendra Health Inc.DEFA14A - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)
- SECSEC Form DEF 14A filed by Accendra Health Inc.DEF 14A - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)
- INSIDERSEC Form 4 filed by Pesicka Edward A4 - ACCENDRA HEALTH INC/VA/ (0000075252) (Issuer)
- INSIDERSEC Form 4 filed by Leon Jonathan A4 - ACCENDRA HEALTH INC/VA/ (0000075252) (Issuer)
ACH FAQ
6 questionsWhat does Accendra Health Inc. do?
Aluminum Corporation of China Limited, together with its subsidiaries, manufactures and sells alumina, primary aluminum, and energy products in the People's Republic of China. The company operates through Alumina, Primary Aluminum, Trading, and Energy segments. The Alumina segment mines for and purchases bauxite and other raw materials; and produces and sells alumina, as well as refined alumina. The Primary Aluminum segment procures alumina and other raw materials, supplemental materials, and electrical power; and produces and sells aluminum and aluminum-related products, such as carbon...Where does ACH stock trade?
Accendra Health Inc. (ACH) is listed on NYSE.What sector and industry is ACH in?
Accendra Health Inc. operates in the Health Care sector, Medical Specialities industry.What are analysts saying about ACH?
Accendra Health Inc. has had 2 recent analyst actions on file. The most recent action was from Goldman: Neutral on 2022-08-25.What companies are similar to ACH?
Notable peers in the same industry include UNH (UnitedHealth Group Incorporated), ANTM (Anthem Inc.), ELV (Elevance Health Inc.), CI (The Cigna Group), HUM (Humana Inc.). Compare ACH side-by-side with any of them on Quantisnow.How can I track ACH on Quantisnow?
Quantisnow aggregates Accendra Health Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ACH to receive live email and push alerts on every new disclosure.